Teratogenic Effects of Antiepileptic Medications

Neurologic Clinics

Volumn 27, Issue 4, 2009, Pages 993-1002

  Tomson, Torbjörn ^a,b   Battino, Dina ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Antiepileptic drugs; Birth defects; Epilepsy; Pregnancy; Teratogenicity

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

COGNITIVE DEVELOPMENT; CONGENITAL MALFORMATION; EPILEPSY; HUMAN; OBSERVATIONAL STUDY; PERINATAL PERIOD; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; REGISTER; REVIEW; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; PREGNANCY; TERATOGENS;

EID: 70350053139     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2009.06.006     Document Type: Review

References (47)

1. Gaily E. Development and growth in children of epileptic mothers: a prospective controlled study. Acta Obstet Gynecol Scand 70 7-8 (1991) 631-632
2. Holmes L.B., Harvey E.A., Coull B.A., et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 344 15 (2001) 1132-1138
3. Meador K.J., Pennell P.B., Harden C.L., et al. Pregnancy registries in epilepsy: a consensus statement on health outcomes. Neurology 71 14 (2008) 1109-1117
4. Tomson T., and Hiilesmaa V. Epilepsy in pregnancy. BMJ 335 (2007) 769-773
5. Meadow S.R. Anticonvulsant drugs and congenital abnormalities. Lancet 2 7581 (1968) 1296
6. Tomson T., and Battino D. Teratogenicity of antiepileptic drugs: state of the art. Curr Opin Neurol 18 (2005) 135-140
7. Tomson T., Battino D., French J., et al. Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav 11 3 (2007) 277-282
8. Battino D., and Tomson T. Management of epilepsy during pregnancy. Drugs 67 18 (2007) 2727-2746
9. Artama M., Auvinen A., Raudaskoski T., et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64 11 (2005) 1874-1878
10. Wide K., Winbladh B., and Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93 2 (2004) 174-176
11. Cunnington M., Ferber S., and Quarteny G. Effect of dose on frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 48 6 (2007) 1207-1210
12. Tomson T., and Battino D. The management of epilepsy in pregnancy. In: Shorvon S., and Pedley T.A. (Eds). The blue books of neurology: the epilepsies 3 (2009), Saunders Elsevier, Philadelphia 241-264
13. Fried S., Kozer E., Nulman I., et al. Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf 27 3 (2004) 197-202
14. Lindhout D., and Schmidt D. In-utero exposure to valproate and neural tube defects. Lancet 1 8494 (1986) 1392-1393
15. Rosa F.W. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324 10 (1991) 674-677
16. Kallen A.J. Maternal carbamazepine and infant spina bifida. Reprod Toxicol 8 3 (1994) 203-205
17. Holmes L.B., Baldwin E.J., Smith C.R., et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 70 (2008) 2152-2218
18. Dolk H., Jentink J., Loane M., et al. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?. Neurology 71 (2008) 714-722
19. Available at:. www.janusinfo.org Accessed February 10, 2009
20. Holmes L.B., Wyszynski D.F., Lieberman E., and The A.E.D. (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 61 5 (2004) 673-678
21. Wyszynski D.F., Nambisan M., Surve T., et al. Antiepileptic drug pregnancy registry: increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64 6 (2005) 961-965
22. Hernandez-Diaz S., Smith C.R., Wyszynski D.F., et al. Risk of major malformations among infants exposed to carbamazepine during pregnancy. Birth Def Res (Part A): Clin Mol Teratol 79 (2007) 357
23. Holmes L.B., Smith C.R., and Hernandez-Diaz S. Pregnancy registries: larger sample sizes essential. Birth Defects Res 82 (2008) 307
24. Morrow J., Russell A., Guthrie E., et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatr 77 2 (2006) 193-198
25. Vajda F.J., Hitchcock A., Graham J., et al. The Australian register of antiepileptic drugs in pregnancy: the first 1002 pregnancies. Aus NZ J Obstet Gynecol 47 (2007) 468-474
26. Kondo T., Kaneko S., Amano Y., et al. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia 37 (1996) 1242-1244
27. Samren E.B., van Duijn C.M., Christiaens G.C., et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46 5 (1999) 739-746
28. Fonager K., Larsen H., Pedersen L., et al. Birth outcomes in women exposed to anticonvulsant drugs. Acta Neurol Scand 101 5 (2000) 289-294
29. Hvas C.L., Henriksen T.B., Ostergaard J.R., et al. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG 107 7 (2000) 896-902
30. Long L. Levetiracetam monotherapy during pregnancy: a case series. Epilepsy Behav 4 (2003) 447-448
31. Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 4 3 (2003) 310-317
32. Kaaja E., Kaaja R., and Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 60 4 (2003) 575-579
33. Meischenguiser R., D'Giano C.H., and Ferraro S.M. Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav 5 2 (2004) 163-167
34. Ornoy A., and Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 75 6 (1996) 517-520
35. ten Berg K., Samrén E.B., van Oppen A.C., et al. Levetiracetam use and pregnancy outcome. Reprod Toxicol 20 (2005) 175-178
36. Hunt S., Craig J., Russell A., et al. Levetiracetam in pregnancy: preliminary experience from the UK epilepsy and pregnancy register. Neurology 67 10 (2006) 1876-1879
37. Hunt S., Russell A., Smithson W.H., et al. Topiramate in pregnancy: preliminary experience from the UK epilepsy and pregnancy register. Neurology 71 4 (2008) 272-276
38. Adab N., Tudur S.C., Vinten J., et al. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev 3 (2004) CD004848
39. Adab N., Jacoby A., Smith D., et al. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatr 70 1 (2001) 15-21
40. Vinten J., Adab N., Kini U., et al. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64 6 (2005) 949-954
41. Gaily E., Kantola-Sorsa E., Hiilesmaa V., et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62 1 (2004) 28-32
42. Eriksson K., Viinikainen K., Monkkonen A., et al. Children exposed to valproate in utero: population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65 3 (2005) 189-200
43. Meador K.J., Baker G.A., Browning N., et al. NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360 16 (2009) 1597-1605
44. Samren E.B., van Duijn C.M., Koch S., et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38 9 (1997) 981-990
45. Kaneko S., Battino D., Andermann E., et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 33 2-3 (1999) 145-158
46. Pennell P.B., Peng L., Newport D.J., et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring and seizure frequency. Neurology 70 (2008) 2130-2216
47. Harden C.L., Meador K.J., Pennell P.B., et al. Practice parameter update: management issues for women with epilepsy. Focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73 2 (2009) 126-132